News Quantified

ONTX – onconova therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Traws Pharma Announces New Employee Inducement Grants [Yahoo! Finance]

Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company [Yahoo! Finance]

Traws Pharma Announces New Employee Inducement Grants

Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company

Onconova Therapeutics, Inc. (NASDAQ: ONTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

-4.4%

BEAT

-5.9%

BEAT

-4.2%

MISS

Form 8-K Traws Pharma, Inc. For: Apr 01

Form DEFA14A Traws Pharma, Inc.

Form 4 Traws Pharma, Inc. For: Apr 01 Filed by: Redfield Robert

Form 4 Traws Pharma, Inc. For: Apr 01 Filed by: Pauza Charles David

Form 4 Traws Pharma, Inc. For: Apr 01 Filed by: CAUTREELS WERNER

Top News Gainers

11/30 Hedge Funds Watching Proteon Therapeutics Inc (PRTO) From Afar [Yahoo! Finance News] 58.4%

11/26 Onconova Therapeutics Inc (NASDAQ: ONTX) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating. 35.0%

1/3 Form 424B5 Onconova Therapeutics, 18.7%

2/4 Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City 17.2%

11/18 Form SC 13G/A Onconova Therapeutics, Filed by: TYNDALL CAPITAL PARTNERS L P 17.1%

10/19 Onconova Therapeutics Inc (NASDAQ: ONTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 16.8%

8/20 Onconova Therapeutics Inc (NASDAQ: ONTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $2.50 price target on the stock. 14.8%

3/3 Onconova Therapeutics Inc (NASDAQ: ONTX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 10.1%

7/16 Onconova Therapeutics Inc (NASDAQ: ONTX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 9.9%

12/9 Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical T 9.5%

Top News Decliners

11/21 Onconova Therapeutics Announces Exclusive License Agreement with Knight Therapeutics for Rigosertib in Canada -64.4%

12/31 Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market -28.7%

9/20 Form 4 Onconova Therapeutics, For: Sep 18 Filed by: TYNDALL CAPITAL PARTNERS L P -27.7%

11/26 Form 4 Onconova Therapeutics, For: Nov 25 Filed by: OLER ABRAHAM N. -26.8%

11/19 Form 8-K Onconova Therapeutics, For: Nov 19 -24.6%

3/24 Form 8-K Onconova Therapeutics, For: Mar 24 -19.2%

9/13 Form FWP Onconova Therapeutics, Filed by: Onconova Therapeutics, Inc. -18.9%

10/29 Form S-1 Onconova Therapeutics, -18.2%

11/14 Form S-1/A Onconova Therapeutics, -16.7%

3/12 Onconova Therapeutics Inc (NASDAQ: ONTX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day